Glaukos Shares Outstanding 2014-2024 | GKOS

Glaukos shares outstanding for the quarter ending September 30, 2024 were 0.055B, a 13.07% increase year-over-year.

  • Glaukos 2023 shares outstanding were 0.048B, a 2.08% increase from 2022.
  • Glaukos 2022 shares outstanding were 0.047B, a 2.2% increase from 2021.
  • Glaukos 2021 shares outstanding were 0.046B, a 4.33% increase from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Glaukos Shares Outstanding 2014-2024 | GKOS

  • Glaukos 2023 shares outstanding were 0.048B, a 2.08% increase from 2022.
  • Glaukos 2022 shares outstanding were 0.047B, a 2.2% increase from 2021.
  • Glaukos 2021 shares outstanding were 0.046B, a 4.33% increase from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$194.7B
Intuitive Surgical (ISRG)$191.9B
Alcon (ALC)$42.1B
Edwards Lifesciences (EW)$41.4B
IQVIA Holdings (IQV)$34.7B
IDEXX Laboratories (IDXX)$34.1B
DexCom (DXCM)$29.2B
STERIS (STE)$20.9B
Waters (WAT)$20.5B
SONOVA HOLDING (SONVY)$20.3B
Hologic (HOLX)$18.2B
Fresenius Medical Care AG KGaA (FMS)$13B
Sysmex ADR (SSMXY)$12.7B
Globus Medical (GMED)$11.3B
Penumbra (PEN)$9.1B
Teleflex (TFX)$9B
Masimo (MASI)$8.8B
PROCEPT BioRobotics (PRCT)$4.9B
Integer Holdings (ITGR)$4.5B
Veracyte (VCYT)$3B
Inari Medical (NARI)$3B
LivaNova (LIVN)$2.8B
TransMedics (TMDX)$2.8B
Nihon Kohden (NHNKY)$2.3B
Elekta AB (EKTAY)$2.2B
Tandem Diabetes Care (TNDM)$1.8B
RxSight (RXST)$1.8B
Integra LifeSciences Holdings (IART)$1.8B
Alphatec Holdings (ATEC)$1.4B
Artivion (AORT)$1.1B